Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    February 2017
  1. KWAK BO, Lee HJ, Kang HM, Oh CE, et al
    Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.
    Arch Virol. 2017 Feb 15. doi: 10.1007/s00705-017-3276.
    PubMed     Text format     Abstract available


  2. WU W, Liu S, Yu P, Tao X, et al
    Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Arch Virol. 2017 Feb 10. doi: 10.1007/s00705-017-3263.
    PubMed     Text format     Abstract available


  3. ZHANG M, Ge J, Wen Z, Chen W, et al
    Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.
    Arch Virol. 2017;162:359-367.
    PubMed     Text format     Abstract available


    January 2017
  4. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


    December 2016
  5. ANDOH K, Yamazaki K, Honda Y, Honda T, et al
    Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  6. MOEINI S, Saeidi M, Fotouhi F, Mondanizadeh M, et al
    Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format    


  7. ZHOU Y, Yang X, Wang H, Zeng F, et al
    The establishment and characteristics of cell-adapted IBV strain H120.
    Arch Virol. 2016;161:3179-87.
    PubMed     Text format     Abstract available


    October 2016
  8. ASTRAY RM, Jorge SA, Pereira CA
    Rabies vaccine development by expression of recombinant viral glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  9. LI J, Yu T, Zhang F, Wang X, et al
    Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  10. MIAO FM, Zhang SF, Wang SC, Liu Y, et al
    Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  11. SUN Y, Yang C, Li J, Li L, et al
    Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  12. MOEINI S, Saeidi M, Fotouhi F, Mondanizdeh M, et al
    Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  13. MADAPONG A, Temeeyasen G, Saeng-Chuto K, Tripipat T, et al
    Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  14. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  15. ZHU Y, Wang GH, Cui YD, Cui SJ, et al
    Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.
    Arch Virol. 2016;161:2543-7.
    PubMed     Text format     Abstract available


    July 2016
  16. ANDRADE LG, Albarnaz JD, Mugge FL, David BA, et al
    Vaccinia virus dissemination requires p21-activated kinase 1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  17. SAMY A, El-Enbaawy MI, El-Sanousi AA, Nasef SA, et al
    Initiation and regulation of immune responses to immunization with whole inactivated vaccines prepared from two genetically and antigenically distinct lineages of Egyptian influenza A virus subtype H5N1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  18. QUINTILIO W, de Freitas FA, Rodriguez D, Kubrusly FS, et al
    Vitamins as influenza vaccine adjuvant components.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  19. NAVID MT, Li Y, Zhou M, Cui M, et al
    Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  20. MENG XY, Luo Y, Liu Y, Shao L, et al
    A triplex real-time PCR for differential detection of classical, variant and Bartha-K61 vaccine strains of pseudorabies virus.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  21. MORIMOTO K, Khawplod P, Sato Y, Virojanapirom P, et al
    Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  22. JAGADESH A, Salam AA, Mudgal PP, Arunkumar G, et al
    Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  23. BALL C, Forrester A, Ganapathy K
    Detection of variant infectious bronchitis viruses in Sri Lanka (2012-2015).
    Arch Virol. 2016;161:1697-9.
    PubMed     Text format     Abstract available


  24. SVIBEN D, Forcic D, Kurtovic T, Halassy B, et al
    Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.
    Arch Virol. 2016;161:1455-67.
    PubMed     Text format     Abstract available


    March 2016
  25. BINJAWADAGI B, Lakshmanappa YS, Longchao Z, Dhakal S, et al
    Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  26. YANG H, Li Z, Lin H, Wang W, et al
    A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  27. MOSTAFA A, Abdelwhab EM, Slanina H, Hussein MA, et al
    Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  28. DEL VALLE A, Garcia AA, Barron BL
    Detection of mumps virus genotype H in two previously vaccinated patients from Mexico City.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  29. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. JIN H, Xia X, Liu B, Fu Y, et al
    High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
    Arch Virol. 2016;161:705-10.
    PubMed     Text format     Abstract available


    February 2016
  31. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  32. YANG X, Zhou Y, Li J, Fu L, et al
    Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  33. CHEN Y, He S, Sun L, Luo Y, et al
    Genetic variation, pathogenicity, and immunogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus strain XH-GD at different passage levels.
    Arch Virol. 2016;161:77-86.
    PubMed     Text format     Abstract available


    December 2015
  34. DO LP, Doan YH, Nakagomi T, Kaneko M, et al
    Molecular characterisation of wild-type G1P[8] and G3P[8] rotaviruses isolated in Vietnam 2008 during a vaccine trial.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  35. XIAO XX, Zhang Y, Liu JX, Wei QL, et al
    Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  36. NDASHE K, Simulundu E, Hang'ombe BM, Moonga L, et al
    Molecular characterization of infectious bursal disease viruses detected in vaccinated commercial broiler flocks in Lusaka, Zambia.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  37. LEI H, Peng X, Zhao D, Jiao H, et al
    Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  38. WANG S, Sun C, Zhang S, Zhang X, et al
    Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: